330 related articles for article (PubMed ID: 22086831)
21. Acquired coagulopathy in patients with left ventricular assist devices.
Muslem R; Caliskan K; Leebeek FWG
J Thromb Haemost; 2018 Mar; 16(3):429-440. PubMed ID: 29274191
[TBL] [Abstract][Full Text] [Related]
22. Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients.
Crow S; Chen D; Milano C; Thomas W; Joyce L; Piacentino V; Sharma R; Wu J; Arepally G; Bowles D; Rogers J; Villamizar-Ortiz N
Ann Thorac Surg; 2010 Oct; 90(4):1263-9; discussion 1269. PubMed ID: 20868825
[TBL] [Abstract][Full Text] [Related]
23. Anticoagulation and bleeding in patients with ventricular assist devices: walking the tightrope.
Kurien S; Hughes KA
AACN Adv Crit Care; 2012; 23(1):91-8. PubMed ID: 22290095
[TBL] [Abstract][Full Text] [Related]
24. Low incidence of gastrointestinal bleeding and pump thrombosis in patients receiving the INCOR LVAD system in the long-term follow-up.
Iacovoni A; Centofanti P; Attisani M; Verde A; Terzi A; Senni M; Maiani M; Baronetto A; Livi U; Frigerio M; Rinaldi M
Int J Artif Organs; 2015 Oct; 38(10):542-7. PubMed ID: 26541278
[TBL] [Abstract][Full Text] [Related]
25. Clinical and In Vitro Evidence That Left Ventricular Assist Device-Induced von Willebrand Factor Degradation Alters Angiogenesis.
Bartoli CR; Zhang DM; Hennessy-Strahs S; Kang J; Restle DJ; Bermudez C; Atluri P; Acker MA
Circ Heart Fail; 2018 Sep; 11(9):e004638. PubMed ID: 30354363
[TBL] [Abstract][Full Text] [Related]
26. Current axial-flow devices--the HeartMate II and Jarvik 2000 left ventricular assist devices.
John R
Semin Thorac Cardiovasc Surg; 2008; 20(3):264-72. PubMed ID: 19038737
[TBL] [Abstract][Full Text] [Related]
27. Ventricular assist device therapy.
Sayer G; Naka Y; Jorde UP
Cardiovasc Ther; 2009; 27(2):140-50. PubMed ID: 19426251
[TBL] [Abstract][Full Text] [Related]
28. Pulsatile vs. continuous flow in ventricular assist device therapy.
Loor G; Gonzalez-Stawinski G
Best Pract Res Clin Anaesthesiol; 2012 Jun; 26(2):105-15. PubMed ID: 22910084
[TBL] [Abstract][Full Text] [Related]
29. Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II).
Klovaite J; Gustafsson F; Mortensen SA; Sander K; Nielsen LB
J Am Coll Cardiol; 2009 Jun; 53(23):2162-7. PubMed ID: 19497443
[TBL] [Abstract][Full Text] [Related]
30. What is the optimal anticoagulation in patients with a left ventricular assist device?
Rossi M; Serraino GF; Jiritano F; Renzulli A
Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):733-40. PubMed ID: 22761118
[TBL] [Abstract][Full Text] [Related]
31. Association of Nasal Mucosal Vascular Alterations, Gastrointestinal Arteriovenous Malformations, and Bleeding in Patients With Continuous-Flow Left Ventricular Assist Devices.
Patel SR; Madan S; Saeed O; Algodi M; Luke A; Gibber M; Goldstein DJ; Jorde UP
JACC Heart Fail; 2016 Dec; 4(12):962-970. PubMed ID: 27744088
[TBL] [Abstract][Full Text] [Related]
32. Gastrointestinal Bleeding During Continuous-Flow Left Ventricular Assist Device Support: State of the Field.
Kataria R; Jorde UP
Cardiol Rev; 2019; 27(1):8-13. PubMed ID: 30520778
[TBL] [Abstract][Full Text] [Related]
33. Left Ventricular Assist Devices Impact Hospital Resource Utilization Without Affecting Patient Mortality in Gastrointestinal Bleeding.
Li F; Hinton A; Chen A; Mehta NK; Eldika S; Zhang C; Hussan H; Conwell DL; Krishna SG
Dig Dis Sci; 2017 Jan; 62(1):150-160. PubMed ID: 27858326
[TBL] [Abstract][Full Text] [Related]
34. Hematologic effects of continuous flow left ventricular assist devices.
Slaughter MS
J Cardiovasc Transl Res; 2010 Dec; 3(6):618-24. PubMed ID: 20835786
[TBL] [Abstract][Full Text] [Related]
35. Gastrointestinal Bleeding Following LVAD Placement from Top to Bottom.
Cushing K; Kushnir V
Dig Dis Sci; 2016 Jun; 61(6):1440-7. PubMed ID: 27017225
[TBL] [Abstract][Full Text] [Related]
36. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.
John R; Kamdar F; Liao K; Colvin-Adams M; Miller L; Joyce L; Boyle A
J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1318-23. PubMed ID: 19026822
[TBL] [Abstract][Full Text] [Related]
37. Risk Factors and Outcomes of Gastrointestinal Bleeding in Left Ventricular Assist Device Recipients.
Joy PS; Kumar G; Guddati AK; Bhama JK; Cadaret LM
Am J Cardiol; 2016 Jan; 117(2):240-4. PubMed ID: 26651456
[TBL] [Abstract][Full Text] [Related]
38. Gastrointestinal bleeding after continuous-flow left ventricular device implantation: review of pathophysiology and management.
Guha A; Eshelbrenner CL; Richards DM; Monsour HP
Methodist Debakey Cardiovasc J; 2015; 11(1):24-7. PubMed ID: 25793026
[TBL] [Abstract][Full Text] [Related]
39. Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices.
Crow S; John R; Boyle A; Shumway S; Liao K; Colvin-Adams M; Toninato C; Missov E; Pritzker M; Martin C; Garry D; Thomas W; Joyce L
J Thorac Cardiovasc Surg; 2009 Jan; 137(1):208-15. PubMed ID: 19154927
[TBL] [Abstract][Full Text] [Related]
40. Understanding Left Ventricular Assist Devices.
Aissaoui N; Jouan J; Gourjault M; Diebold B; Ortuno S; Hamdan A; Latremouille C; Pirracchio R; Morshuis M
Blood Purif; 2018; 46(4):292-300. PubMed ID: 30048974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
